Abstract:As we age, the ability to regenerate and repair skeletal muscle damage declines, partially due to increasing dysfunction of muscle resident stem cells—satellite cells (SC). Recent evidence implicates cellular senescence, which is the irreversible arrest of proliferation, as a potentiator of SC impairment during aging. However, little is known about the role of senescence in SC, and there is a large discrepancy in senescence classification within skeletal muscle. The purpose of this study was to develop a model of senescence in skeletal muscle myoblasts and identify how common senescence-associated biomarkers respond. Low-passage C 2 C 12 myoblasts were treated with bleomycin or vehicle and then evaluated for cytological and molecular senescence markers, proliferation status, cell cycle kinetics, and differentiation potential. Bleomycin treatment caused double-stranded DNA breaks, which upregulated p21 mRNA and protein, potentially through NF-κB and senescence-associated super enhancer (SASE) signaling ( p < 0.01). Consequently, cell proliferation was abruptly halted due to G2/M-phase arrest ( p < 0.01). Bleomycin-treated myoblasts displayed greater senescence-associated β-galactosidase staining ( p < 0.01), which increased over several days. These myoblasts remained senescent following 6 days of differentiation and had significant impairments in myotube formation ( p < 0.01). Furthermore, our results show that senescence can be maintained despite the lack of p16 gene expression in C 2 C 12 myoblasts. In conclusion, bleomycin treatment provides a valid model of damage-induced senescence that was associated with elevated p21, reduced myoblast proliferation, and aberrant cell cycle kinetics, while confirming that a multi-marker approach is needed for the accurate classification of senescence within skeletal muscle.

Restoration of CPEB4 prevents muscle stem cell senescence during aging

4E-BP1 counteracts human mesenchymal stem cell senescence via maintaining mitochondrial homeostasis

Dissecting Murine Muscle Stem Cell Aging through Regeneration Using Integrative Genomic Analysis

Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways.

Overexpression of ERBB4 Rejuvenates Aged Mesenchymal Stem Cells and Enhances Angiogenesis Via PI3K/AKT and MAPK/ERK Pathways

Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration

Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation

CPEB1 directs muscle stem cell activation by reprogramming the translational landscape

BTG2 acts as an inducer of muscle stem cell senescence

Exercise rejuvenates quiescent skeletal muscle stem cells in old mice through restoration of Cyclin D1

Muscle-secreted Granulocyte Colony-Stimulating Factor Functions As Metabolic Niche Factor Ameliorating Loss of Muscle Stem Cells in Aged Mice.

Senolytic treatment rescues blunted muscle hypertrophy in old mice

Depletion of SAM leading to loss of heterochromatin drives muscle stem cell ageing

Immune aging impairs muscle regeneration via macrophage-derived anti-oxidant selenoprotein P

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice

Aerobic exercise suppresses CCN2 secretion from senescent muscle stem cells and boosts muscle regeneration in aged mice

Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice

Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging

Muscle 4EBP1 activation modifies the structure and function of the neuromuscular junction in mice

Loss of Muscle Stem Cells in Aged Mice is Replenished by Muscle-Secreted Niche Factor G-CSF